Blog Category

News

predictive oncology

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

/

2025-03-03

Renovaro and BioSymetrics Announce Definitive Merger Agreement 

/

2025-02-26

Renovaro Announces $15 million in Equity Committed

/

2025-02-26

Renovaro Issues Shareholder Letter and Provides Corporate Update

/

2025-01-07

Nathen Fuentes

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

/

2025-01-07

predictive oncology

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

/

2025-01-06

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

/

2024-12-30

RenovaroCube Receives Approval of Lumina Project

/

2024-12-23

Renovaro Regains Compliance

/

2024-12-20

Renovaro Issues Shareholder Letter

/

2024-11-04

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics

/

2024-10-17

Renovaro Announces Strategic Restructuring and Leadership Transition

/

2024-10-16